ZGENE AS has a total of 12 patent applications. Its first patent ever was published in 1999. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are SNIPR TECH LTD, DCPRIME B V and BIOMICS BIOTECHNOLOGIES CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Basic materials chemistry | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Pasteurisation | |
#4 | Wine | |
#5 | Preservation of human bodies | |
#6 | Climate change adaptation technologies | |
#7 | Enzymes | |
#8 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Gojkovic Zoran | 10 |
#2 | Kristoffersen Peter | 5 |
#3 | Zoran Gojkovic | 1 |
#4 | Karlsson Anna | 1 |
#5 | Willer Oldenborg Mette | 1 |
#6 | Peter Kristoffersen | 1 |
#7 | Johansson Magnus | 1 |
Publication | Filing date | Title |
---|---|---|
WO2010000270A1 | Prodrug activation therapy for the treatment of malignant brain tumours | |
EP1974026A2 | Mutant deoxyadenosine kinase enzymes and their use | |
ZA200803326B | Dekkera/Brettanomyces cytosine deaminases and their use | |
WO2007036233A2 | Dekkera/brettanomyces cytosine deaminases and their use | |
US2007248543A1 | Chicken Deoxycytidine and Deoxyadenosine Kinase Enzymes and Their Use | |
US2007202120A1 | Yellow Fever Mosquito Deoxyribonucleoside Kinases And Its Use | |
EP1137764A1 | New medical use of gene and vector encoding a multisubstrate deoxyribonucleosidase |